سیاست‌های تشویق نوآوری باز

نوع مقاله: مقاله پژوهشی

نویسندگان

1 دانشجوی دکتری مدیریت فناوری، دانشگاه آزاد اسلامی، واحد علوم و تحقیقات، تهران

2 استادیار مؤسسه مطالعات و پژوهش‌های بازرگانی، تهران

چکیده

تغییرات سریع فناورانه و نوآوری‌های فراوان، حاصل تغییر دیدگاه شرکت‌ها و دولت‌ها از فعالیت‌های منزوی و جزیره‌ای به سمت همکاری‌ها و فعالیت‌های جمعی است. این رویکرد در پیشینه موضوع تحت عنوان نوآوری باز شناخته شده و توجه محققان بسیاری را به خود جلب کرده است. به منظور شناسایی این مفهوم و آشنایی با چگونگی پشتیبانی سیاست‌ها از آن، در این مقاله ضمن بررسی مفهوم، سابقه و روش‌های نوآوری باز، به شیوه‌های سیاست‌گذاری و ابزارهای سیاستی ارتقاء آن پرداخته شده است. بر این اساس یک ماتریس 3×3 مشتمل بر دو بُعد برای نوآوری (درون‌سو، برون‌سو و دوسویه) و فرآیند دانش (خلق، انتشار و بهره‌برداری) ارائه و ابزارهای سیاستی تقویت هر یک از این ابعاد پیشنهاد شده‌اند. در پایان نیز شیوه همکاری فناورانه و نوآورانه در طول زنجیره ارزش داروهای زیستی در ایران، از طریق مطالعه موردی یک شرکت داروساز بررسی شده است.
 

کلیدواژه‌ها


عنوان مقاله [English]

Policies for Promoting Open Innovation

نویسندگان [English]

  • Hadi Siadati 1
  • Masoud Afshari Mofrad 2
1 Ph.D Candidate in Management of Technology, Islamic Azad University, Science and Research Branch, Tehran, Iran
2 Assistant Professor, Institute for Trade Studies and Research, Tehran, Iran
چکیده [English]

Rapid technological changes and profuse innovations are the result of moving from isolated efforts to collaboration for creation of new sources of value among firms and governments. Such approach toward innovation has been known as open innovation in the literature and many researchers have studied its different aspects. In order to introduce this concept and investigate how policies could support it, this study tries to present the concept, its history and modes and policy tools to promote it among firms. Based on the literature review, a 3×3 matrix with two dimensions including Innovation Direction (Inbound, Outbound, and Coupled) and Knowledge process (Creation, Diffusion and Exploitation) is proposed in order to categorize the policy tools. Finally, a case of open innovation affairs among Iranian biopharmaceutical firms is studied to recognize the gaps in public policies to boost open innovation in the industry.
 

کلیدواژه‌ها [English]

  • Open innovation
  • Policy Making
  • Policy tools
  • Biopharmaceuticals
[1] Chesbrough, H. (2003). Open Innovation. Cambridge. MA: Harvard University Press.

[2] OECD. (2006). Open innovation in global networks. Organization for Economic Cooperation and Development, Policy document.

[3] Boyer, R. (2004). New growth regimes, but still institutional diversity. Socio-Economic Review, 2(1), 1-32.

[4] Teece, D. (1988). Technological Change and the Nature of the Firm in Technical Change and Economic Theory. Edited by Dosi, G., Freeman, C., Nelson, R., Silveiberg, G., and Soete, L. Francis Printer, London.

[5] Hollingsworth, J. R. (1991). The logic of coordinating American manufacturing sectors. Governance of the American economy, 5, 35.

[6] Herstad, S. J., Bloch, C., Ebersberger, B., & Van De Velde, E. (2010). National innovation policy and global open innovation: exploring balances, tradeoffs and complementarities. Science and Public Policy, 37(2), 113-124.

[7] Rothwell, R. (1994). Towards the fifth-generation innovation process. International marketing review, 11(1), 7-31.

[8] Marinova, D., & Phillimore, J. (2003). Models of innovation. In Shavinina, V. (Ed.). International handbook on innovation. Amsterdam: Elserver.

[9] Tidd, J. (2006). A review of innovation models. Imperial College London, discussion paper 1.

[10] Berkhout, A. J., Hartmann, D., Van Der Duin, P., & Ortt, R. (2006). Innovating the innovation process. International journal of technology management, 34(3-4), 390-404.

[11] Boehm, G., & Fredericks, L. J. (2010). Strategic innovation management in global industry networks: The TFT LCD Industry. Asian Journal of Business Management, 2(4), 110-120.

[12] Barbieri, J. C., & Álvares, A. C. T. (2016). Sixth generation innovation model: description of a success model. RAI Revista de Administração e Inovação, 13(2), 116-127.

[13] Chesbrough, H. W. (2006). Open innovation: The new imperative for creating and profiting from technology. Harvard Business Press.

[14] Raja, B. H. (2015). Open innovation in pharmaceutical industry: A case study of Eli Lilly. M.Sc. Thesis in KTH University, Sweden.

[15] Bianchi, M., Cavaliere, A., Chiaroni, D., Frattini, F., & Chiesa, V. (2011). Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis. Technovation, 31(1), 22-33.

[16] Zhang, J. (2014). Global drug discovery outsourcing market gaining momentum. Life science leader.

[17] Uddin, M. B., & Akhter, B. (2011). Strategic alliance and competitiveness: theoretical framework. Researchers World, 2(1), 43-54.

[18] Festel, G., & De Cleyn, S. H. (2011). R&D Spin-outs in the Pharmaceutical Industry. Journal of Business Chemistry, 8(3), 101-113.

[19] Harwood, R. (2016). The Open Innovation Methods Matrix. 100 open, Accessed through: https://www.100open.com/the-open-innovation-methods-matrix-part-1/

[20] Van der Zee, F., Rehfeld, D., & Hamza, C. (2015). Open innovation in industry, including 3D printing. Disponible en ligne sous http://www. europarl. europa. eu/RegData/etudes/STUD/2015/563445/IPOL_STU.

[21] Chesbrough, H., Vanhaverbeke, W., Bakici, T., & Lopez-Vega, H. (2011). Open innovation and public policy in Europe. Barcelona, Spain: ESADE Business School, Science Business Innovation Board.

[22] Moedas, C. (2016). Open Innovation, Open Science and Open to the World–A Vision for Europe. Luxembourg: Publications Office of the European Union.

[23] De Jong, J. P., Kalvet, T., & Vanhaverbeke, W. (2010). Exploring a theoretical framework to structure the public policy implications of open innovation. Technology Analysis & Strategic Management, 22(8), 877-896.

[24] Naghizadeh, R. (2017). The Pattern of Cooperation Between Small Knowledge-Based Firms and Industrial and Economic Firms; by Guaranteed-Buys Method. Journal of Science and Technology Policy, 9(2), 67-81. {In Persian}.

[25] Yun, J. J., Won, D., Hwang, B., Kang, J., & Kim, D. (2015). Analysing and simulating the effects of open innovation policies: Application of the results to Cambodia. Science and Public Policy, 42(6), 743-760.

[26] Salim, A., Razavi, M. R., & Afshari-Mofrad, M. (2017). Foreign direct investment and technology spillover in Iran: The role of technological capabilities of subsidiaries. Technological Forecasting and Social Change, 122, 207-214.

[27] Salim, A., Razavi, M. R., Radfar, R., Ghaffari, F., & Afshari-Mofrad, M. (2018). Assessing the Effects of Foreign Direct Investment on Technology Spillovers to Subsidiaries in Iran. Journal of Science & Technology Policy, 10(2), 47-55. {In Persian}.

[28] Ghazinoory, S., & Shakeri, R. (2017). Integrating industrial, trade and technology policies in Iran’s biopharmaceutical industry. Institute for Trade Studies and Research, Tehran. {In Persian}.

[29] Afshari-Mofrad, M., & Salim, A. (2019). Iranian firms in biopharmaceutical value chain: where to go now?. Journal of Science and Technology Policy Management.